Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Completed 3 Active not recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Solid Tumor, Adult 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 Lung Neoplasms 1 Efficacy 1

Interventions

Cisplatin 38 Carboplatin 28 Gemcitabine 23 Docetaxel 20 Radiotherapy 18 Etoposide 15 Paclitaxel 13 Erlotinib Hydrochloride 13 Vinorelbine 11 Drug Therapy 11 pembrolizumab 9 aumolertinib 9 apatinib 9 Pemetrexed 9 Gefitinib 9 osimertinib 7 endostar protein 7 Thoracic Surgery, Video-Assisted 7 Blood Specimen Collection 7 camrelizumab 6 anlotinib 6 Vinblastine 6 Surgical Procedures, Operative 6 sintilimab 5 Radiosurgery 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Bevacizumab 5 durvalumab 4 Mitomycin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × sotorasib × Clear all

NCT05311709 2023-11-09

SOLUCOM

Vestre Viken Hospital Trust

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡